Abstract:Background TNF-α-blocking therapy is a successful treatment strategy for rheumatoid arthritis (RA), but is associated with reduced resistance to tuberculosis. We have developed a vaccine against mouse TNF-α (TNF-KLH) which protects mice from collagen-induced arthritis (CIA) and collagen-antibodies-induced arthritis (CAIA). We aimed at modelizing the infectious risk/benefit ratio of TNF-α neutralisation by comparing different strategies of TNF-α targeting in experimental Mycobacterium tuberculosis infection. Materials and methods 4 groups (TNF-KLH, etanercept, KLH, PBS) of 10 C57BL/6 mice were compared with TNF deficient mice (TNF -/-). Vaccines were emulsified in IFA before i.m. administration (days −44, –31, −17 and −4). Other treatments were given from D0. All groups were infected at day 0 by 104 cfu of Mycobacterium tuberculosis (H37Rv virulent strain). Mouse groups were divided in two arms: one was euthanized 28 days post-infection, the lasting mice were euthanized 56 days post-infection. Bacterial burden was evaluated in lungs. Cellular infiltration was studied by immunohistological analysis. Results A sustained anti-TNF-α antibody production was obtained in vaccinated mice. At day 28 of Mycobacteria infection, bacterial burden, organ weights, neutrophils and B cells infiltration were similar between TNF-KLH, KLH and PBS groups. At this time point, histological analysis showed higher surface of granuloma in liver of etanercept and TNF-/- groups than TNF-KLH group. At day 56 post infection, etanercept group presented higher surface of liver and lung granuloma than TNF-KLH and KLH groups. These observations were in accordance with a progression of the disease in etanercept group, whereas such effect was not retrieved in TNF-KLH and immunocompetent groups (KLH, PBS). Conclusion Our results indicate that anti-TNF-α vaccination could protect mice from inflammatory arthritis without deeply altering host immunity against infection, suggesting the existence of two distinct pathophysiologic thresholds for TNF-α inhibition, one for arthritis improvement, the other for infection facilitation. These thresholds might be dependend on the TNF inhibition strategy.

The Preventive Effect of Adjuvant-Free Administration of TNF-PADRE Autovaccine on Collagen-Ii-induced Rheumatoid Arthritis in Mice.

[Experiment Treatment of Collagen-Induced Arthritis in Rats with Recombinant Plasmid Containing Vasoactive Intestinal Peptide Gene].

Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.

Co-Expression of Il-18 Binding Protein and Il-4 Regulates Th1/Th2 Cytokine Response in Murine Collagen-Induced Arthritis

Efficacy of mIL-18BP and mIL-4 adenoviral coexpression gene therapy for cyclooxygenase-2 and inducible nitric oxide synthetase in murine collagen-induced arthritis

Therapeutic role of a vaccine targeting RANKL and TNF-α on collagen-induced arthritis.

Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine to Protect Mice from Experimental Colitis.

Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis

Therapeutic Effects Of Taci-Ig On Rats With Adjuvant-Induced Arthritis Via Attenuating Inflammatory Responses

Protective Effects of Overexpression TCR Vbeta5.2-HSP70 and TCR Vbeta8.2-HSP70 Against Collagen-Induced Arthritis in Rats.

[Serum IL-18 Levels in Mice with Collagen-Induced Arthritis Treated by Recombinant Adenovirus Containing Mil-18Bp and Mil-4 Fusion Gene].

TNF-α Inhibitor Ameliorates Immune-Related Arthritis and Pneumonitis in Humanized Mice.

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

Therapeutic Effect of Tolerogenic Antigen Presenting Cell on Collagen-Induced Arthritis in Rats

06.11 Anti-tnf-α Vaccination Protects from Experimental Arthritis Without Negatively Affecting Resistance to Mycobacterium Tuberculosis Infection

The Protective Antibodies Induced by a Novel Epitope of Human TNF-α Could Suppress the Development of Collagen-Induced Arthritis

The experimental study on the effect of rhTNFR:Fc and methtotrexate-rhTNFR:Fc on joint destruction of collagen-induced arthritis rat

Immunoregulatory Roles of T Cells Vaccine in Collagen Induced Arthritis

Adoptive Induced Antigen-Specific Treg Cells Reverse Inflammation in Collagen-Induced Arthritis Mouse Model

[Effects of TNF-alpha receptor blocking peptide on adjuvant arthritis in rats].

Anti-T-Cell Receptor Antibody Treatment of Rats with Established Autologous Collagen-Induced Arthritis - Suppression of Arthritis Without Reduction of Anti-Type-Ii Collagen Autoantibody Levels